We are live on
!
Find out more
Neuberger Berman Group Portfolio holdings
AUM
$131B
1-Year Est. Return
28.36%
This Fund
S&P 500
This Quarter
Est. Return
+3.72%
1 Year Est. Return
+28.36%
3 Year Est. Return
+86.21%
5 Year Est. Return
+112.87%
10 Year Est. Return
+467.9%
AUM
$134B
AUM Growth
-$2.51B
(-1.8%)
Cap. Flow
-$4.46B
Cap. Flow
% of AUM
-3.32%
Top 10 Holdings %
Top 10 Hldgs %
24%
Holding
2,213
New
182
Increased
966
Reduced
894
Closed
102
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NBCR
Neuberger Core Equity ETF
NBCR
|
+$190M |
| 2 |
United Rentals
URI
|
+$166M |
| 3 |
Constellation Energy
CEG
|
+$147M |
| 4 |
UGI
UGI
|
+$134M |
| 5 |
Celestica
CLS
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SNDK
Sandisk
SNDK
|
+$246M |
| 2 |
S&P Global
SPGI
|
+$201M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$197M |
| 4 |
Aon
AON
|
+$184M |
| 5 |
JPMorgan Chase
JPM
|
+$172M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.15% |
| 2 | Financials | 14.23% |
| 3 | Industrials | 11.38% |
| 4 | Healthcare | 9.42% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
JetBlue
JBLU
$2.28B
| $46.5K | ﹤0.01% |
10,219
| – | – |
|
2052
Erasca
ERAS
$6.3B
| $46K | ﹤0.01% |
12,358
+1,253
| +11% | +$3.52K |
|
2053
Tronox
TROX
$932M
| $44.3K | ﹤0.01% |
+10,635
| New | +$40.5K |
|
2054
Sana Biotechnology
SANA
$871M
| $43.7K | ﹤0.01% |
10,746
-432
| -4% | -$1.93K |
|
|
RC
2055
Ready Capital
RC
$258M
| $42.8K | ﹤0.01% |
19,632
+9,222
| +89% | +$25.8K |
|
2056
Pacific Biosciences
PACB
$435M
| $40.1K | ﹤0.01% |
+21,435
| New | +$41.2K |
|
|
BHR
2057
Braemar Hotels & Resorts
BHR
$156M
| $39.5K | ﹤0.01% |
+13,756
| New | +$37.1K |
|
2058
Gossamer Bio
GOSS
$82.9M
| $38.9K | ﹤0.01% |
+12,558
| New | +$35.8K |
|
2059
Talkspace
TALK
$874M
| $38.2K | ﹤0.01% |
+10,528
| New | +$33.4K |
|
2060
Prime Medicine
PRME
$527M
| $37.9K | ﹤0.01% |
+10,915
| New | +$48.6K |
|
2061
Vaalco Energy
EGY
$570M
| $37.7K | ﹤0.01% |
10,351
-106
| -1% | -$392 |
|
2062
Xerox
XRX
$387M
| $36.5K | ﹤0.01% |
+15,409
| New | +$45.6K |
|
2063
Maravai LifeSciences
MRVI
$969M
| $36.4K | ﹤0.01% |
+11,193
| New | +$37.7K |
|
|
SVC
2064
Service Properties Trust
SVC
$1.04B
| $35.7K | ﹤0.01% |
3,878
+1,025
| +36% | +$10.3K |
|
2065
Hyliion Holdings
HYLN
$635M
| $33.8K | ﹤0.01% |
18,392
+1,028
| +6% | +$2.07K |
|
2066
Coty
COTY
$2.42B
| $33.3K | ﹤0.01% |
10,813
-13,479
| -55% | -$49K |
|
2067
Cocrystal Pharma
COCP
$11.3M
| $31.2K | ﹤0.01% |
31,886
| – | – |
|
|
EU
2068
enCore Energy
EU
$212M
| $31.2K | ﹤0.01% |
+12,571
| New | +$35.9K |
|
2069
SmartRent
SMRT
$195M
| $30.2K | ﹤0.01% |
+14,937
| New | +$24.5K |
|
2070
Quantum-Si Incorporated
QSI
$155M
| $29.5K | ﹤0.01% |
+26,820
| New | +$43.7K |
|
2071
Definitive Healthcare
DH
$72M
| $29.3K | ﹤0.01% |
+10,217
| New | +$28.3K |
|
2072
DocGo
DCGO
$64.3M
| $29.1K | ﹤0.01% |
+33,154
| New | +$35.4K |
|
2073
Clover Health Investments
CLOV
$2.2B
| $28.6K | ﹤0.01% |
12,185
+1,985
| +19% | +$5.43K |
|
2074
Cerus
CERS
$433M
| $28.6K | ﹤0.01% |
13,874
+1,187
| +9% | +$2.06K |
|
2075
New Fortress Energy
NFE
$92.1M
| $28.3K | ﹤0.01% |
24,798
-554
| -2% | -$817 |
|
Similar funds
Neuberger Berman Group's Q4 2025 Portfolio in Review
As of Q4 2025, Neuberger Berman Group held 2,213 positions worth $134B, down 1.8% from $137B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Neuberger Berman Group withdrew a net $4.46B in Q4 2025, closing 102 positions and reducing 894 holdings. Its most notable exit was Verona Pharma, an estimated $36M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Financials and Industrials.
Against the trend, Neuberger Berman Group opened a new position in BillionToOne Inc worth $57.4M.
- Neuberger Berman Group's largest Q4 2025 buy was BillionToOne Inc: 700,867 shares worth $57.4M.
- Neuberger Berman Group added most to Neuberger Core Equity ETF in Q4 2025, an estimated $190M increase.
- Neuberger Berman Group's biggest Q4 2025 reduction was Sandisk, cutting an estimated $246M.
- Neuberger Berman Group fully exited Verona Pharma in Q4 2025, selling an estimated $36M.
- Neuberger Berman Group's ten largest holdings make up 24% of its $134B portfolio in Q4 2025.
- Neuberger Berman Group opened 182 new positions and closed 102 in Q4 2025.
- Neuberger Berman Group's portfolio value fell 1.8% quarter-over-quarter to $134B.
Based on Neuberger Berman Group's 13F filing for Q4 2025, filed 13 Feb 2026.